Drug makers seeking to stay afloat

Published: 2012-12-12 06:59:00

Updated: 2012-12-12 06:59:00

During this year, it looks as if a series of government policies and outside pressures are at last forcing drug makers to change their problematic business models.

Realizing that the threat of punishment alone would not work, the Ministry of Health and Welfare resorted to the drastic measure o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK